SAMHSA Accepting Applications for 1.5 Million in Funding of Physician Clinical Support System for the Treatment of Substance Use Disorders (PCSS) Program

Date: 7/17/2009
Media Contact: SAMHSA Press Office
Telephone: 240-276-2130

SAMHSA Accepting Applications for 1.5 Million in Funding of Physician Clinical Support System for the Treatment of Substance Use Disorders (PCSS) Program

The Substance Abuse and Mental Health Services Administration (SAMHSA), is accepting applications for fiscal year (FY) 2010 for the Physician Clinical Support System for the Treatment of Substance Use Disorders (PCSS) cooperative agreement. The purpose of this program is to enhance and further develop the current DATA Physician Clinical Support System designed to assist physicians in treating patients dependent on heroin or prescription opioid drugs with FDA approved products containing buprenorphine.

While there has been some success with physician adoption of buprenorphine for opioid addiction treatment, the stigma of addiction continues to discourage primary care physicians from obtaining training in addiction treatment. The lack of physician experience, concerns over practical issues, and limited understanding of the appropriate role of medication in opioid treatment also appear to be factors in the slow adoption of this form of treatment by the medical profession.

PCSS is one of SAMHSA’s infrastructure programs. SAMHSA’s Infrastructure Grants support an array of activities to help the grantee build a solid foundation for delivering and sustaining effective substance abuse prevention and/or treatment and/or mental health services. Awardees may pursue diverse strategies and methods to achieve their infrastructure development and capacity expansion goals. The plan put forward in the grant application must show the linkages among needs, the proposed infrastructure development strategy, and increased system capacity that will enhance and sustain effective programs and services.

It is expected that approximately $1.5 million will be available to fund a cooperative agreement with one grantee for an average annual award amount of up to $500,000 per year for up to three years. The actual award amount may vary, depending on the availability of funds and the performance of the grantee. The cooperative agreement will be awarded by SAMHSA’s Center for Substance Abuse Treatment.

WHO CAN APPLY: Eligibility is limited to the national professional medical organizations authorized by the Drug Addiction Treatment Act of 2000 (DATA) to carry out the training of physicians desiring to prescribe and/or dispense FDA approved buprenorphine products for the treatment of addictive disorders.

[See Section III-1 of this RFA for complete eligibility information.]


HOW TO APPLY: Applications for No. T1-10-001 are available by calling SAMHSA’s Information Line at 1-877-SAMHSA7 [TDD: 1 800-487-4889] or by downloading the application at http://www.samhsa.gov/grants/apply.aspx. Applicants are encouraged to apply online using www.grants.gov.

APPLICATION DUE DATE: September 17, 2009. Applications must be received by the due date and time to be considered for review. Please review carefully Section IV-3 of the application announcement for submission requirements.

Applicants with questions about program issues should contact:
Anthony Campbell at 240-276-2702 or email to anthony.campbell@samhsa.hhs.gov

For questions on grants management issues contact: William Reyes at 240-276-1406 or email to william.reyes@samhsa.hhs.gov.


abrir aquí para acceder al informe:
SAMHSA Accepting Applications for 1.5 Million in Funding of Physician Clinical Support System for the Treatment of Substance Use Disorders (PCSS) Program